In 2023, the import of contraceptives to France stood at 19.867 million USD. The forecast for 2024 indicates a decline to 15.678 million USD, continuing a downward trend with forecasts of 11.867 million USD in 2025, 8.1322 million USD in 2026, 4.4721 million USD in 2027, and 0.88518 million USD in 2028. This data suggests a consistent decrease in import value over the forecasted period, reflecting a negative compound annual growth rate (CAGR). Such a trend hints at either decreased demand, improved domestic production, or shifts in market dynamics.

Future trends to watch for:

Changes in domestic contraceptive production capabilities.
Shifts in consumer preferences towards alternative products or methods.
Policy and regulatory impacts affecting imports or health sector dynamics.
Global supply chain developments that might influence import costs and availability.